Capital at an early stage gives you an increased opportunity to test your idea, build the right business model, create a team and reconcile your idea with the market.
We have extensive experience of investing in early companies. With us as early investors, your opportunities for continued financing through our investor networks, private investors, VC funds and industrial investors also increase.
UU Invest AB is part of Uppsala’s innovation system. Here is competence that is critical at an early stage. These can be, for example, patent and IP issues, market research, business development and exchange of experience, and contact with senior people who, like you, have taken their research further.
UU Invest AB invests for the long-term. Once we have made an initial investment you can expect our commitment and support to continue for 5-15 years. Our long-term perspective gives you the opportunity to grow slowly and to develop the company towards making a profit in the future. It gives you peace of mind to build your business.
Through UU Innovation’s business and patent advisor, your research can undergo analyzes and verification surveys that point to opportunities and possible problems. It is a valuable collaboration for us that paves the way for future phases in the possible company formation.
Did you know that all our profits are reinvested in other research projects? In this way, your success contributes to more researchers being able to develop their ideas.
Show:
30 år av framgångsrika startups från universitetet. UU Invest är Uppsala universitets investeringsbolag med uppdrag att investera i forsk-
ningsbaserade bolag. Sedan starten 1995 har vi investerat i mer än 115 bolag – företag som idag återfinns inom olika branscher där de bidrar till samhällsnytta och tillväxt.
I år firar vi 30 år av aktivt ägande och konstaterar att många av våra portföljbolag utvecklats
till starka aktörer på nationella och internationella marknader.
Development is progressing rapidly at the new company Duck Technologies. If everything goes according to plan, the hope is that the company’s first product will be ready for the market within two years. What remains is to scale up and package a new opportunity to save energy by reducing heat intake through, among other things, windows in buildings and cars.
Mesenkia Therapeutics, backed by UU Invest, is developing a groundbreaking treatment for glioblastoma, the most aggressive brain cancer. The startup is preparing clinical trials to create a drug aimed at extending patients’ lives.
SoundSim360, developed by Professor Ken Mattsson and Dr. Gustav Eriksson, is an advanced sound simulation tool for precise sound level predictions that handles complex acoustics, including low-frequency sounds for wind turbines, arenas, and home theater systems.
UU Invest hosts your project so that you can establish necessary agreements with collaborative partners, hire key personnel to investigate or develop the concept, and also assist ‘hands on’ in negotiations and strategic work.
Ida-Maria Sintorn, along with her colleagues in the SimSearch project, is developing new technology for image processing of microscopic images. The focus is to make it easier, faster, and safer for researchers to extract relevant information from large amounts of data while retaining control over their own data.
Oscar Verho and his research network are focused on creating more efficient ways to produce fuels from water. The path involves advanced interdisciplinary development and a sustainable, efficient electrode with the potential to make green hydrogen production more cost-effective.
PapersHive is one of UU Invest’s 55 portfolio companies. With an AI-based search technology, the company collects information from all medical databases in one place. This saves both time and money for pharmaceutical companies, CROs and medical technology companies.
Applications for VentureChallenge 2023 are now closed. A new call for applications will open again in the first quarter of 2024.
Up to 500,000 SEK for your research-based business idea. UU Invest, in collaboration with UU Innovation, is now conducting a call for start-up capital of up to 500,000 SEK for your research-based business idea.
Meet Gunilla Lundmark, CEO of UU Invest, and Malin Graffner Nordberg, Head of UU Innovation. With different roles and expertise, they work towards the same overall goal – to contribute to Uppsala University’s efforts to take research forward and utilise knowledge in society.
Ulf Landegren och hans forskningsgrupp ligger bakom banbrytande forskning som lett till nya innovationer som framgångsrikt förvaltats och utvecklats i en rad olika bolag. Rarity Bioscience med vd Linus Bosaeus är ett av de senaste i raden.